Reasons for Initiation of Canakinumab of Patients with Systemic Juvenile Idiopathic Arthritis: A Retrospective Medical Chart Review from the United States

被引：0
|
作者：
Hur, Peter [1 ]
Ionescu-Ittu, Raluca [2 ]
Manceur, Ameur M. [2 ]
Lomax, Kathleen G. [1 ]
Cammarota, Jordan [3 ]
Xie, Jipan [4 ]
Sanghera, Navneet [1 ]
Grom, Alexei A. [5 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Anal Grp Inc, Montreal, PQ, Canada
[3] Anal Grp Inc, Washington, DC USA
[4] Anal Grp Inc, Los Angeles, CA USA
[5] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2698
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Long-term Efficacy and Safety of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results From a Phase III
    Brunner, Hermine
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Kone-Paut, Isabelle
    Marzan, Katherine
    Wulffraat, Nico
    Schneider, Rayfel
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Vritzali, Eleni
    Lheritier, Karine
    Martini, Alberto
    Lovell, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 64 - 66
  • [42] An Exploratory Analysis of Predictors of Response from 12-Weeks of Canakinumab Therapy in Patients with Active Systemic Juvenile Idiopathic Arthritis.
    Brunner, Hermine I.
    Ruperto, Nicola
    Kone-Paut, Isabelle
    Magnusson, Bo
    Ozen, Seza
    Sztajnbok, Flavio
    Anton, Jordi
    Barash, Judith
    Berner, Reinhard
    Corona, Fabrizia
    Lheritier, Karine
    Gaillez, Corine
    Martini, Alberto
    Lovell, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S413 - S413
  • [43] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A SINGLE-CENTER STUDY
    Alexeeva, E.
    Krekhova, E.
    Dvoryakovskaya, T.
    Isaeva, K.
    Chomakhidze, A.
    Chistyakova, E.
    Lomakina, O.
    Denisova, R.
    Mamutova, A.
    Fetisova, A.
    Gautier, M.
    Vankova, D.
    Shingarova, M.
    Kriulin, I.
    Alshevskaya, A.
    Moskalev, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1776 - 1777
  • [44] Retrospective Evaluation of Patients with Systemic Juvenile Idiopathic Arthritis: A Single-centre Experience
    Baglan, Esra
    Ozdel, Semanur
    Gungor, Tulin
    Celikkaya, Evra
    Karakaya, Deniz
    Bulbul, Mehmet
    AKTUELLE RHEUMATOLOGIE, 2022, 47 (02) : 152 - 157
  • [45] Pivotal Phase III study demonstrates substantial symptom relief in patients with systemic juvenile idiopathic arthritis treated with canakinumab
    不详
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (06) : 721 - 721
  • [46] CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS AFTER SINGLE DOSE OF CANAKINUMAB
    Wulffraat, N.
    Kallinich, T.
    McCann, L.
    Brik, R.
    Rutkowska-Sak, L.
    Ferrandiz, M.
    Lheritier, K.
    Kim, D.
    Gnanasakthy, A.
    Ozdogan, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 266 - 267
  • [47] Canakinumab Treatment in Patients with Still's Disease: A Pooled Analysis of Systemic Juvenile Idiopathic Arthritis Data By Age Groups
    Feist, Eugen
    Quartier, Pierre
    Fautrel, Bruno
    Schneider, Rayfel
    Sfriso, Paolo
    Efthimiou, Petros
    Cantarini, Luca
    Lheritier, Karine
    Leon, Karolynn
    Speziale, Antonio
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [48] CANAKINUMAB IS A RESCUE TREATMENT FOR MACROPHAGE ACTIVATION SYNDROME IN PATIENTS WITH SYSTEMIC ONSET JUVENILE IDIOPATHIC ARTHRITIS: SINGLE CENTER EXPERIENCE
    Kostik, M.
    Isupova, E.
    Chikova, I.
    Likhacheva, T.
    Masalova, V.
    Snegireva, L.
    Dubko, M.
    Gaidar, E.
    Kaneva, M.
    Kornishina, T.
    Kalashnikova, O.
    Chasnyk, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 937 - 937
  • [49] Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment
    Kostik, M. M.
    Isupova, E. A.
    Chikova, I. A.
    Dubko, M. F.
    Masalova, V. V.
    Snegireva, L. S.
    Kalashnikova, O., V
    Chasnyk, V. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) : 335 - 341
  • [50] Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Followup Study
    Brunner, Hermine L.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Schneider, Rayfel
    Kone-Paut, Isabelle
    Schikler, Kenneth
    Marzan, Katherine
    Wulffraat, Nico
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Vritzali, Eleni
    Lovell, Daniel J.
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345